心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2020 AHA科学声明：降低成人心脏和胸主动脉手术患者围术期卒中风险的考虑因素

2020-08-26 美国心脏协会 Circulation . 2020 Aug 26;

心脏手术围术期卒中

2020年8月，美国心脏协会(AHA)发布了降低成人心脏和胸主动脉手术患者围术期卒中风险的考虑因素的科学声明。围术期卒中是心脏手术中最严重的并发症之一，其发病机制是多因素的，这给预防带来了挑战。本文主

中文标题：

2020 AHA科学声明：降低成人心脏和胸主动脉手术患者围术期卒中风险的考虑因素

英文标题：

Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association

发布机构：

美国心脏协会

发布日期：

2020-08-26

简要介绍：

2020年8月，美国心脏协会(AHA)发布了降低成人心脏和胸主动脉手术患者围术期卒中风险的考虑因素的科学声明。围术期卒中是心脏手术中最严重的并发症之一，其发病机制是多因素的，这给预防带来了挑战。本文主要针对术前、术中以及术后的相关策略提出指导，目的是减低围术期风险并改善围术期卒中患者的预后。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 AHA科学声明：降低成人心脏和胸主动脉手术患者围术期卒中风险的考虑因素.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9345c1c00196a9ec, title=2020 AHA科学声明：降低成人心脏和胸主动脉手术患者围术期卒中风险的考虑因素, enTitle=Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association, guiderFrom=Circulation . 2020 Aug 26;, authorId=0, author=, summary=2020年8月，美国心脏协会(AHA)发布了降低成人心脏和胸主动脉手术患者围术期卒中风险的考虑因素的科学声明。围术期卒中是心脏手术中最严重的并发症之一，其发病机制是多因素的，这给预防带来了挑战。本文主, cover=https://img.medsci.cn/202097/1599413025630_2020535.jpg, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会（AHA，American Heart Association）是心脏病学领域比较正要的学会之一，致力于心脏病和卒中的预防与治疗，提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等，有官方杂志《美国心脏协会杂志》，提供心血管疾病和卒中相关的指南及专家共识，更新的比较快。, copyright=0, guiderPublishedTime=Wed Aug 26 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，美国心脏协会(AHA)发布了降低成人心脏和胸主动脉手术患者围术期卒中风险的考虑因素的科学声明。围术期卒中是心脏手术中最严重的并发症之一，其发病机制是多因素的，这给预防带来了挑战。本文主要针对术前、术中以及术后的相关策略提出指导，目的是减低围术期风险并改善围术期卒中患者的预后。</p> </div> </div> </div>, tagList=[TagDto(tagId=472, tagName=心脏手术), TagDto(tagId=106420, tagName=围术期卒中)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=472, guiderKeyword=心脏手术, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2815, appHits=138, showAppHits=0, pcHits=366, showPcHits=2677, likes=1, shares=13, comments=5, approvalStatus=1, publishedTime=Mon Sep 07 01:33:10 CST 2020, publishedTimeString=2020-08-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Sep 07 01:23:58 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:06:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 AHA科学声明：降低成人心脏和胸主动脉手术患者围术期卒中风险的考虑因素.pdf)])
2020 AHA科学声明：降低成人心脏和胸主动脉手术患者围术期卒中风险的考虑因素.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1051481, encodeId=960210514818e, content=没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87762433617, createdName=123bfb13m36暂无昵称, createdTime=Wed Sep 15 13:58:49 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956023, encodeId=ecc695602385, content=有没有翻译的全文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a13d2091753, createdName=0988, createdTime=Sun Apr 11 22:14:13 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922439, encodeId=515092243985, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Wed Feb 03 12:48:17 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884136, encodeId=eca2884136ee, content=多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/141c99cdc65c44bf83b75c8508f8f782/2288a4580d98499baacf5be18653e6a0.jpg, createdBy=b9945378046, createdName=ms6000000572095183, createdTime=Thu Sep 10 10:38:07 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2021-09-15 123bfb13m36暂无昵称

    没积分

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1051481, encodeId=960210514818e, content=没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87762433617, createdName=123bfb13m36暂无昵称, createdTime=Wed Sep 15 13:58:49 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956023, encodeId=ecc695602385, content=有没有翻译的全文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a13d2091753, createdName=0988, createdTime=Sun Apr 11 22:14:13 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922439, encodeId=515092243985, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Wed Feb 03 12:48:17 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884136, encodeId=eca2884136ee, content=多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/141c99cdc65c44bf83b75c8508f8f782/2288a4580d98499baacf5be18653e6a0.jpg, createdBy=b9945378046, createdName=ms6000000572095183, createdTime=Thu Sep 10 10:38:07 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2021-04-11 0988

    有没有翻译的全文

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1051481, encodeId=960210514818e, content=没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87762433617, createdName=123bfb13m36暂无昵称, createdTime=Wed Sep 15 13:58:49 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956023, encodeId=ecc695602385, content=有没有翻译的全文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a13d2091753, createdName=0988, createdTime=Sun Apr 11 22:14:13 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922439, encodeId=515092243985, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Wed Feb 03 12:48:17 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884136, encodeId=eca2884136ee, content=多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/141c99cdc65c44bf83b75c8508f8f782/2288a4580d98499baacf5be18653e6a0.jpg, createdBy=b9945378046, createdName=ms6000000572095183, createdTime=Thu Sep 10 10:38:07 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2021-02-03 nvc0520

    很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1051481, encodeId=960210514818e, content=没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87762433617, createdName=123bfb13m36暂无昵称, createdTime=Wed Sep 15 13:58:49 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956023, encodeId=ecc695602385, content=有没有翻译的全文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a13d2091753, createdName=0988, createdTime=Sun Apr 11 22:14:13 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922439, encodeId=515092243985, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Wed Feb 03 12:48:17 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884136, encodeId=eca2884136ee, content=多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/141c99cdc65c44bf83b75c8508f8f782/2288a4580d98499baacf5be18653e6a0.jpg, createdBy=b9945378046, createdName=ms6000000572095183, createdTime=Thu Sep 10 10:38:07 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-10 ms6000000572095183

    多多学习

    0

相关指南

2018 国际共识声明：心脏手术患者直接口服抗凝药物围术期管理

欧洲心胸外科协会(EACTS,European Association for Cardio-Thoracic Surgery) · 2018-09-27

2018 ESA指南：成人择期非心脏手术的术前评估（更新版）

欧洲麻醉学会(ESA,European Society of Anaesthesiology) · 2018-05-02

2017 EACTS/EACTA指南：成人心脏手术患者血液管理

欧洲心胸外科协会(EACTS,European Association for Cardio-Thoracic Surgery) · 2017-10-03

2017 EACTS指南：成人心脏手术围术期药物治疗

欧洲心胸外科协会(EACTS,European Association for Cardio-Thoracic Surgery) · 2017-10-06

拓展阅读

2017 EACTS指南：成人心脏手术围术期药物治疗

欧洲心胸外科协会(EACTS,European Association for Cardio-Thoracic Surgery) · 2017-10-06

2017 EACTS/EACTA指南：成人心脏手术患者血液管理

欧洲心胸外科协会(EACTS,European Association for Cardio-Thoracic Surgery) · 2017-10-03

2018 ESA指南：成人择期非心脏手术的术前评估（更新版）

欧洲麻醉学会(ESA,European Society of Anaesthesiology) · 2018-05-02

2018 国际共识声明：心脏手术患者直接口服抗凝药物围术期管理

欧洲心胸外科协会(EACTS,European Association for Cardio-Thoracic Surgery) · 2018-09-27

2022 SFAR指南：体外循环或非体外循环下心脏手术促进术后恢复

法国麻醉和重症医学学会(SFAR,French Society for Anaesthesia and Intensive Care) · 2022-04-30

2023 STS/SCA/AmSECT临床实践指南：成人心脏手术相关急性肾损伤的预防

美国心血管麻醉医师协会(SCA,Society of Cardiovascular Anesthesiologists) · 2022-12-19